News Releases Keyword search Year None202220212020201920182017201620152014201320122011201020092008 1/12/2022 AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery 1/10/2022 AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Print Page RSS Feeds
Keyword search Year None202220212020201920182017201620152014201320122011201020092008 1/12/2022 AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery 1/10/2022 AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
1/12/2022 AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery
